H. Bismuth et al., SURGICAL-TREATMENT OF HEPATOCELLULAR CARCINOMAS IN NONCIRRHOTIC LIVER- EXPERIENCE WITH 68 LIVER RESECTIONS, World journal of surgery, 19(1), 1995, pp. 35-41
Hepatocellular carcinoma (HCC), although generally associated with cir
rhosis, can also develop in a noncirrhotic liver. To study HCCs in non
cirrhotic liver, their surgical management and prognosis, 68 patients
with partial hepatectomy for this disease were analyzed. The liver, in
all cases, appeared normal macroscopically at laparotomy, but in 13 c
ases (19%) it presented some slight histologic modifications, such as
steatosis or portal fibrosis. Five patients had a fibrolamellar carcin
oma. The mean diameter of the tumors was 8.8 cm. Sixteen patients (23.
5%) were treated preoperatively by embolization or chemoembolization.
Surgical procedures consisted in a major hepatectomy (three segments o
r more) in 72% of the cases. Operative mortality and morbidity were, r
espectively, 2.9% and 19.0%. The 1-, 3-, 5-, and 10-year survivals and
the survivals without recurrence were 74%, 52%, 40%, and 26% and 69%,
43%, 33%, and 19%, respectively. Recurrence, which was in most cases
intrahepatic, occurred in 39 of the 66 survivors (59%) and was treated
by rehepatectomy in 12 cases, providing long survivals. These data ju
stify extensive, aggressive surgery for HCCs in noncirrhotic liver and
show the need for long-term follow-up to detect late recurrence, as s
urgery for recurrent disease prolongs survival.